XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
$ in Thousands
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Dec. 31, 2021 $ 1 $ 1 [1] $ 227,804 $ (123,054) $ (13,764) $ 90,988
Balance, shares at Dec. 31, 2021 1,252,299 590,851     40,620    
Net (loss) income [1] (8,906) (8,906)
Preferred dividends-Series B [1] (749) (749)
Stock-based compensation [1] 955 955
Issuance of shares – preferred offering [1] 957 957
Issuance of shares - preferred offering, shares 66,857              
Restricted stock units vested [1]
Restricted stock units vested, shares     573          
Issuance of shares – warrant exercises [1] 738 738
Issuance of shares - warrant exercises, shares     3,580          
Issuance of shares- Notes conversion [1] 1,342 1,342
Issuance of shares- Notes conversion, shares     5,847          
Warrants and valuation issued in relation to debt financing [1] 2,257 2,257
Ending balance, value at Mar. 31, 2022 $ 1 $ 1 [1] 233,304 (131,960) $ (13,764) 87,582
Ending balance, shares at Mar. 31, 2022 1,319,156   600,851     40,620    
Beginning balance, value at Dec. 31, 2021 $ 1 $ 1 [1] 227,804 (123,054) $ (13,764) 90,988
Balance, shares at Dec. 31, 2021 1,252,299 590,851     40,620    
Net (loss) income               (71,628)
Ending balance, value at Sep. 30, 2022 $ 3 $ 1 [1] 273,499 (194,409) $ (13,798) 4,022 69,318
Ending balance, shares at Sep. 30, 2022 3,061,245 62,500 656,610     40,741    
Beginning balance, value at Mar. 31, 2022 $ 1 $ 1 [1] 233,304 (131,960) $ (13,764) 87,582
Balance, shares at Mar. 31, 2022 1,319,156   600,851     40,620    
Net (loss) income [1] (6,557) (6,557)
Preferred dividends-Series B [1] (1,382) (1,382)
Stock-based compensation [1] 1,064 1,064
Issuance of shares – preferred offering $ 1 [1] 8,796 8,797
Issuance of shares - preferred offering, shares 599,232              
Restricted stock units vested [1]
Restricted stock units vested, shares     148          
Issuance of shares – warrant exercises [1] 41 41
Issuance of shares - warrant exercises, shares     200          
Warrants and valuation issued in relation to debt financing [1] 3,060 3,060
Issuance of shares – option exercises [1] 77 77
Issuance of shares - option exercises, shares     3,642          
Issuance of shares-restricted stock [1] 23 23
Issuance of shares-restricted stock, shares     130          
Promissory note conversion to preferred shares $ 1 [1] 13,894 13,895
Promissory note conversion to preferred shares, shares 1,142,857              
Treasury Shares conversion [1] $ (34) (34)
Treasury Shares conversion, shares           121    
Ending balance, value at Jun. 30, 2022 $ 3 $ 1 [1] 258,877 (138,517) $ (13,798) 106,566
Ending balance, shares at Jun. 30, 2022 3,061,245 604,971     40,741    
Net (loss) income [1] (55,892) (272) (56,164)
Preferred dividends-Series B [1] (1,722) (1,722)
Stock-based compensation [1] 879 879
Issuance of shares – preferred offering [1] 4,994 4,994
Issuance of shares - preferred offering, shares   62,500            
Restricted stock units vested [1]
Restricted stock units vested, shares     37          
Issuance of shares- Notes conversion [1] 1,099 1,099
Issuance of shares- Notes conversion, shares     11,734          
Warrants and valuation issued in relation to debt financing [1] 9,631 9,631
Issuance of shares – option exercises [1] 76 76
Issuance of shares-restricted stock [1] 11 11
Issuance of shares-restricted stock, shares     130          
Surrender of warrants for common shares [1] (346) (346)
Surrender of warrants for common shares, shares     29,064          
Issuance of common shares in relation to preferred offering [1]
Issuance of common shares in relation to preferred offerings, shares     7,219          
Contribution to Non-Controlling interest [1] 4,294 4,294
Ending balance, value at Sep. 30, 2022 $ 3 $ 1 [1] 273,499 (194,409) $ (13,798) 4,022 69,318
Ending balance, shares at Sep. 30, 2022 3,061,245 62,500 656,610     40,741    
Net (loss) income [1] (27,360) (108) (27,468)
Preferred dividends-Series B [1] (236) (236)
Stock-based compensation [1] 957 957
Restricted stock units vested [1]
Restricted stock units vested, shares     1,225          
Issuance of shares - option exercises, shares   3,455            
Issuance of shares-restricted stock [1] 2 2
Issuance of shares-restricted stock, shares     130          
Contribution to Non-Controlling interest [1] 492 492
Issuance of shares – securities purchase offering [1] 769 769
Issuance of shares - Securities Purchase offering, shares     45,000          
Issuance of shares –common offering [1] 1,583 1,583
Issuance of shares - common offering, shares     55,556          
Issuance of shares- promissory note conversion [1] 854 854
Issuance of shares- promissory note conversion, shares     23,723          
Issuance of common shares in relation to common offering [1] 1 1
Issuance of common shares in relation to common offerings, shares     6,334          
Ending balance, value at Dec. 31, 2022 $ 3 $ 1 [1] 277,429 (221,769) $ (13,798) 4,406 46,272
Ending balance, shares at Dec. 31, 2022 3,061,245 62,500 788,578     40,741    
Net (loss) income [1] (7,062) (370) (7,432)
Preferred dividends-Series B [1] (131) (131)
Stock-based compensation [1] 865 865
Restricted stock units vested [1]
Restricted stock units vested, shares     5,769          
Issuance of shares- Notes conversion [1] 1,394 1,394
Issuance of shares- Notes conversion, shares     174,505          
Issuance of shares-restricted stock [1] 14 14
Issuance of shares-restricted stock, shares     1,400          
Contribution to Non-Controlling interest [1] 8,758 8,758
Issuance of shares – securities purchase offering [1] 439 439
Issuance of shares - Securities Purchase offering, shares     87,144          
Ending balance, value at Mar. 31, 2023 $ 3 $ 1 [1] 280,010 (228,831) $ (13,798) 12,794 50,179
Ending balance, shares at Mar. 31, 2023 3,061,245 62,500 1,057,396     40,741    
Beginning balance, value at Dec. 31, 2022 $ 3 $ 1 [1] 277,429 (221,769) $ (13,798) 4,406 46,272
Balance, shares at Dec. 31, 2022 3,061,245 62,500 788,578     40,741    
Net (loss) income               (22,705)
Ending balance, value at Sep. 30, 2023 $ 3 $ 1 [1] 286,799 (244,268) $ (13,798) 26,652 55,389
Ending balance, shares at Sep. 30, 2023 3,061,245   1,492,729     40,741    
Beginning balance, value at Mar. 31, 2023 $ 3 $ 1 [1] 280,010 (228,831) $ (13,798) 12,794 50,179
Balance, shares at Mar. 31, 2023 3,061,245 62,500 1,057,396     40,741    
Net (loss) income [1] (8,775) (482) (9,257)
Preferred dividends-Series B [1] (252) (252)
Stock-based compensation [1] 2,232 2,232
Restricted stock units vested [1]
Restricted stock units vested, shares     25,125          
Issuance of shares- Notes conversion [1] 400 400
Issuance of shares- Notes conversion, shares     64,351          
Contribution to Non-Controlling interest [1] 13,543 13,543
Issuance of shares – securities purchase offering [1] 446 446
Issuance of shares - Securities Purchase offering, shares     63,978          
Warrants and valuation issued in relation to debt amendment [1] 1,330 1,330
Issuance of shares-merger shares [1]
Issuance of shares-merger shares, shares     19,800          
Ending balance, value at Jun. 30, 2023 $ 3 $ 1 [1] 284,166 (237,606) $ (13,798) 25,855 58,621
Ending balance, shares at Jun. 30, 2023 3,061,245 62,500 1,230,650     40,741    
Net (loss) income [1] (6,662) 646 (6,016)
Preferred dividends-Series B [1] (38) (38)
Stock-based compensation [1] 595 595
Issuance of shares- Notes conversion [1] 650 650
Issuance of shares- Notes conversion, shares     104,577          
Contribution to Non-Controlling interest [1] 151 151
Issuance of shares – securities purchase offering [1] 770 770
Issuance of shares - Securities Purchase offering, shares     113,502          
Common Shares and Warrants for Series B dividend payment [1] 656 $ 656
Common shares and warrants for series b dividend payment,shares               44,000,000
Ending balance, value at Sep. 30, 2023 $ 3 $ 1 [1] $ 286,799 $ (244,268) $ (13,798) $ 26,652 $ 55,389
Ending balance, shares at Sep. 30, 2023 3,061,245   1,492,729     40,741    
[1] Prior period results have been adjusted to reflect the Reverse Stock Split of the Common Stock at a ratio of 1-for-25 that became effective October 13, 2023. See Note 2, “Basis of Presentation,” for details.